NDAINTRAMUSCULARINJECTABLE
Approved
Mar 2010
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
4
Clinical Trials (4)
Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate
Started Nov 2022
195 enrolled
Advanced Prostate CancerMetastatic Prostate CancerLocally Advanced Prostate Cancer
Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis
Started Jul 2017
300 enrolled
Endometriosis
Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer
Started Jan 2013
126 enrolled
Prostate Cancer
Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study
Started Apr 2008
35 enrolled
Precocious Puberty
Loss of Exclusivity
LOE Date
Jun 30, 2029
40 months away
Patent Expiry
Jun 30, 2029
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 10166181 | Jun 30, 2029 | Product | — |